Dr. Derek Vanamerongen, M.D

NPI: 1487849584
Total Payments
$415,472
2024 Payments
$69,616
Companies
35
Transactions
301

Payment Breakdown by Category

Consulting$354,162 (85.2%)
Other$29,526 (7.1%)
Travel$20,475 (4.9%)
Food & Beverage$6,144 (1.5%)
Research$5,124 (1.2%)
Education$39.95 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $354,162 110 85.2%
Travel and Lodging $20,475 74 4.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,826 10 4.3%
Honoraria $11,700 5 2.8%
Food and Beverage $6,144 98 1.5%
Unspecified $5,124 3 1.2%
Education $39.95 1 0.0%

Payments by Type

General
$410,348
298 transactions
Research
$5,124
3 transactions

Top Paying Companies

Company Total Records Latest Year
Eli Lilly and Company $150,582 83 $0 (2024)
Medtronic, Inc. $75,357 53 $0 (2024)
Medical Device Business Services, Inc. $32,530 32 $0 (2021)
Amgen Inc. $22,870 26 $0 (2024)
PFIZER INC. $20,868 17 $0 (2024)
Gilead Sciences, Inc. $17,470 11 $0 (2020)
Ethicon Endo-Surgery Inc. $15,836 11 $0 (2022)
Lilly USA, LLC $13,800 4 $0 (2024)
GENZYME CORPORATION $10,722 9 $0 (2021)
Novo Nordisk AS $7,160 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $69,616 31 Eli Lilly and Company ($25,850)
2023 $38,412 12 Medtronic, Inc. ($13,961)
2022 $49,039 24 Eli Lilly and Company ($14,300)
2021 $60,280 23 Eli Lilly and Company ($17,050)
2020 $47,036 56 Eli Lilly and Company ($25,662)
2019 $42,681 40 Eli Lilly and Company ($16,400)
2018 $59,140 59 Eli Lilly and Company ($26,500)
2017 $49,268 56 Eli Lilly and Company ($14,920)

All Payment Transactions

301 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/10/2024 Medtronic, Inc. Consulting Fee Cash or cash equivalent $9,380.00 General
12/09/2024 PFIZER INC. CIBINQO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,550.00 General
Category: Inflammation & Immunology
12/09/2024 Eli Lilly and Company Consulting Fee Cash or cash equivalent $4,400.00 General
11/22/2024 Lilly USA, LLC KISUNLA (Drug) Consulting Fee Cash or cash equivalent $4,400.00 General
Category: Neuroscience
11/15/2024 Clinigen, Inc. Honoraria Cash or cash equivalent $200.00 General
11/13/2024 PFIZER INC. CIBINQO (Drug) Travel and Lodging In-kind items and services $1,042.55 General
Category: Inflammation & Immunology
11/13/2024 PFIZER INC. CIBINQO (Drug) Travel and Lodging In-kind items and services $646.30 General
Category: Inflammation & Immunology
11/13/2024 PFIZER INC. CIBINQO (Drug) Travel and Lodging In-kind items and services $530.21 General
Category: Inflammation & Immunology
11/13/2024 PFIZER INC. CIBINQO (Drug) Food and Beverage In-kind items and services $66.66 General
Category: Inflammation & Immunology
09/18/2024 Eli Lilly and Company Consulting Fee Cash or cash equivalent $4,400.00 General
07/12/2024 Clinigen, Inc. Consulting Fee Cash or cash equivalent $1,199.62 General
07/05/2024 Eli Lilly and Company Consulting Fee Cash or cash equivalent $2,750.00 General
06/18/2024 Novo Nordisk AS Consulting Fee Cash or cash equivalent $3,600.00 General
06/18/2024 Novo Nordisk AS Consulting Fee Cash or cash equivalent $1,800.00 General
05/22/2024 Eli Lilly and Company Consulting Fee Cash or cash equivalent $4,400.00 General
05/22/2024 Amgen Inc. Consulting Fee Cash or cash equivalent $3,500.00 General
05/21/2024 Amgen Inc. Consulting Fee Cash or cash equivalent $3,500.00 General
05/21/2024 Amgen Inc. Consulting Fee Cash or cash equivalent $1,500.00 General
05/03/2024 Amgen Inc. Travel and Lodging In-kind items and services $294.98 General
05/03/2024 Amgen Inc. Food and Beverage In-kind items and services $276.74 General
05/03/2024 Amgen Inc. Food and Beverage In-kind items and services $276.74 General
05/03/2024 Amgen Inc. Travel and Lodging In-kind items and services $173.75 General
05/03/2024 Amgen Inc. Travel and Lodging In-kind items and services $173.75 General
05/03/2024 Amgen Inc. Travel and Lodging In-kind items and services $173.75 General
05/03/2024 Amgen Inc. Food and Beverage In-kind items and services $149.38 General

Research Studies & Clinical Trials

Study Name Company Amount Records
A DESCRIPTIVE EXAMINATION OF TRENDS IN HEALTHCARE RESOURCE UTILIZATION OVER A 5-YEAR PERIOD PRIOR TO DIAGNOSIS OF ALZHEIMER'S DISEASE DEMENTIA F. Hoffmann-La Roche AG $361.92 1
TIME COURSE OF PRECURSOR NON-COGNITIVE CONDITIONS 5 YEARS PRIOR TO ALZHEIMER'S DISEASE DEMENTIA DIAGNOSIS F. Hoffmann-La Roche AG $361.92 1

About Dr. Derek Vanamerongen, M.D

Dr. Derek Vanamerongen, M.D is a Gynecology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487849584.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Derek Vanamerongen, M.D has received a total of $415,472 in payments from pharmaceutical and medical device companies, with $69,616 received in 2024. These payments were reported across 301 transactions from 35 companies. The most common payment nature is "Consulting Fee" ($354,162).

Practice Information

  • Specialty Gynecology
  • Location Cincinnati, OH
  • Active Since 09/11/2007
  • Last Updated 09/11/2007
  • Taxonomy Code 207VG0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1487849584

Products in Payments

  • ACTIS (Device) $22,257
  • ATTUNE (Device) $7,902
  • IMLYGIC (Biological) $6,873
  • CIBINQO (Drug) $6,836
  • JEVTANA (Drug) $6,469
  • BEOVU (Drug) $4,642
  • KISUNLA (Drug) $4,400
  • MOUNJARO (Drug) $4,400
  • OLUMIANT (Drug) $4,400
  • ELFABRIO (Drug) $3,000
  • narsoplimab (Drug) $2,932
  • OPZELURA (Drug) $2,725
  • LAMZEDE (Drug) $2,500
  • VENASEAL (Device) $2,500
  • Tresiba (Drug) $1,760
  • 3C Patch Kit (Device) $1,700
  • Victoza (Drug) $1,700
  • XIFAXAN (Drug) $1,375
  • ENHERTU (Drug) $1,167
  • NUCALA (Biological) $1,160

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gynecology Doctors in Cincinnati